Crossref journal-article
American Physiological Society
American Journal of Physiology-Lung Cellular and Molecular Physiology (24)
Abstract

Interleukin (IL)-13, a key mediator of Th2-mediated immunity, contributes to the pathogenesis of asthma and other pulmonary diseases via its ability to generate fibrosis, mucus metaplasia, eosinophilic inflammation, and airway hyperresponsiveness. In these studies, we compared surfactant accumulation in wild-type mice and mice in which IL-13 was overexpressed in the lung. When compared with littermate controls, transgenic animals showed alveolar type II cell hypertrophy under light and electron microscopy. Over time, their alveoli also filled with surfactant in a pulmonary alveolar proteinosis pattern. At the same time, prominent interstitial fibrosis occurs. Bronchoalveolar lavage fluid from these mice had a three- to sixfold increase in surfactant phospholipids. Surfactant proteins (SP)-A, -B, and -C showed two- to threefold increases, whereas SP-D increased 70-fold. These results indicate that IL-13 is a potent stimulator of surfactant phospholipid and surfactant accumulation in the lung. IL-13 may therefore play a central role in the broad range of chronic pulmonary conditions in which fibrosis, type II cell hypertrophy, and surfactant accumulation occur.

Bibliography

Homer, R. J., Zheng, T., Chupp, G., He, S., Zhu, Z., Chen, Q., Ma, B., Hite, R. D., Gobran, L. I., Rooney, S. A., & Elias, J. A. (2002). Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. American Journal of Physiology-Lung Cellular and Molecular Physiology, 283(1), L52–L59.

Authors 11
  1. Robert J. Homer (first)
  2. Tao Zheng (additional)
  3. Geoff Chupp (additional)
  4. Susan He (additional)
  5. Zhou Zhu (additional)
  6. Quingshen Chen (additional)
  7. Bing Ma (additional)
  8. R. Duncan Hite (additional)
  9. Laurice I. Gobran (additional)
  10. Seamus A. Rooney (additional)
  11. Jack A. Elias (additional)
References 50 Referenced 46
  1. 10.1016/S0021-9258(18)70226-3 / J Biol Chem by Bartlett GR. (1959)
  2. 10.1016/S0146-0005(96)80048-6
  3. 10.1152/ajplung.1993.264.6.L543
  4. 10.1183/09031936.00.16583100
  5. 10.1165/ajrcmb.19.1.2900
  6. 10.1172/JCI7325
  7. 10.1034/j.1600-065X.2000.917311.x
  8. 10.1016/S0091-6749(98)70080-6
  9. 10.1042/bj2330111
  10. 10.1172/JCI119758
  11. 10.1016/S0952-7915(99)80006-5
  12. 10.4049/jimmunol.152.5.2421 / J Immunol by Elias JA (1994)
  13. 10.4049/jimmunol.164.5.2585
  14. 10.1016/S0022-2275(20)37864-0 / J Lipid Res by Gilfillan AM (1983)
  15. 10.1152/ajplung.2001.281.6.L1413
  16. 10.1074/jbc.275.11.8032
  17. 10.1164/ajrccm.158.1.9712061
  18. 10.1165/ajrcmb.18.1.2627
  19. 10.1164/ajrccm.159.2.9806064
  20. 10.1183/09031936.97.10020482
  21. 10.1164/ajrccm.159.6.9806145
  22. 10.4049/jimmunol.155.5.2688 / J Immunol by Huang SK (1995)
  23. {'key': 'B23', 'first-page': 'A42', 'volume': '161', 'author': 'Hull W', 'year': '2000', 'journal-title': 'Am J Respir Crit Care Med'} / Am J Respir Crit Care Med by Hull W (2000)
  24. 10.1152/ajplung.2000.278.1.L75
  25. 10.1165/ajrcmb.17.5.2883
  26. 10.1164/ajrccm.160.1.9806155
  27. 10.1084/jem.190.6.875
  28. 10.1038/227680a0
  29. 10.1034/j.1600-065X.2000.917308.x
  30. 10.1084/jem.194.6.809
  31. {'key': 'B31', 'first-page': 'A515', 'volume': '161', 'author': 'LeVine A', 'year': '2000', 'journal-title': 'Am J Respir Crit Care Med'} / Am J Respir Crit Care Med by LeVine A (2000)
  32. 10.1046/j.1365-2222.1997.420885.x
  33. 10.1172/JCI10124
  34. 10.4049/jimmunol.164.11.5866
  35. 10.1165/ajrcmb.15.4.8879185
  36. 10.1006/mgme.1998.2722
  37. {'key': 'B37', 'first-page': '439', 'volume': '131', 'author': 'Rooney SA.', 'year': '1985', 'journal-title': 'Am Rev Respir Dis'} / Am Rev Respir Dis by Rooney SA. (1985)
  38. 10.1016/0005-2760(88)90014-8
  39. 10.1152/ajplung.1999.277.6.L1104
  40. 10.1016/0360-3016(82)90092-X
  41. {'key': 'B41', 'first-page': '308', 'volume': '99', 'author': 'Sime PJ', 'year': '2001', 'journal-title': 'Clin Immunol Immunopathol'} / Clin Immunol Immunopathol by Sime PJ (2001)
  42. {'key': 'B42', 'first-page': 'A218', 'volume': '161', 'author': 'Trask BC', 'year': '2000', 'journal-title': 'Am J Respir Crit Care Med'} / Am J Respir Crit Care Med by Trask BC (2000)
  43. 10.1002/path.1711750409
  44. 10.1073/pnas.100448997
  45. 10.1203/00006450-199606000-00002
  46. 10.1152/physrev.1997.77.4.931
  47. 10.1152/ajplung.1995.268.4.L683
  48. 10.1172/JCI10458
  49. 10.1177/44.10.8813084
  50. 10.1172/JCI5909
Dates
Type When
Created 10 years, 6 months ago (March 3, 2015, 3:17 p.m.)
Deposited 3 months, 2 weeks ago (May 20, 2025, 1:49 p.m.)
Indexed 3 months, 2 weeks ago (May 20, 2025, 2:10 p.m.)
Issued 23 years, 2 months ago (July 1, 2002)
Published 23 years, 2 months ago (July 1, 2002)
Published Print 23 years, 2 months ago (July 1, 2002)
Funders 0

None

@article{Homer_2002, title={Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure}, volume={283}, ISSN={1522-1504}, url={http://dx.doi.org/10.1152/ajplung.00438.2001}, DOI={10.1152/ajplung.00438.2001}, number={1}, journal={American Journal of Physiology-Lung Cellular and Molecular Physiology}, publisher={American Physiological Society}, author={Homer, Robert J. and Zheng, Tao and Chupp, Geoff and He, Susan and Zhu, Zhou and Chen, Quingshen and Ma, Bing and Hite, R. Duncan and Gobran, Laurice I. and Rooney, Seamus A. and Elias, Jack A.}, year={2002}, month=jul, pages={L52–L59} }